Marinus Pharmaceuticals reported $48K in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US USD 2.14M 531K
ALKERMES ALKS:US USD 50.62M 7.74M
Amgen AMGN:US USD 1.59B 78M
Biogen BIIB:US USD 469.5M 14.5M
Eisai 4523:JP JPY 45.13B 2.27B
Esperion Therapeutics ESPR:US USD 6.51M 2.67M
Gilead Sciences GILD:US USD 1.4B 47M
Intercept Pharmaceuticals ICPT:US USD 424K 115K
Intra Cellular Therapies ITCI:US USD 5.85M 1.2M
Neurocrine Biosciences NBIX:US USD 6.1M 1.3M
Ptc Therapeutics PTCT:US USD 14.01M 4.37M
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Supernus Pharmaceuticals SUPN:US USD 25.88M 5.42M
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M
YTE INCY:US USD 49.28M 4.05M